Global Leukemia Screening Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 96

Report ID: 19744

Currently, there are no standard leukemia screening methods recommended for regularly testing the leukemia affected patients. Specifically, no leukemia screening test has been reliably confirmed enough to detect the cancer in its early stages before the development of symptoms. Research and development for the leukemia screening is going on, and there is still much to be known about the exact causes of leukemia. As the understanding continues to increase, scientists are gaining a greater knowledge of possible ways to prevent, screen and treat this condition.
Leukemia is commonly caused because of the exposure to radiations, changing lifestyle, genetic mutations, and environmental conditions. Leukemia cases are more commonly found in adults and are observed to develop with aging. Thus, increasing aging population and high occurrence of leukemia are the factors rising the leukemia screening market. Also, novel advancements and R&D in the oncology sector and growing number of biotechnology companies, may also expected to boost the market growth.
Globally, North America has a prominent leukemia screening market followed by Europe because of increasing awareness in patients, technological advancements, supportive regulatory regulations and a sorted healthcare infrastructure. The market in Asia Pacific is expected to grow due to the prevalence of unmet needs. Improving healthcare infrastructure and increase in the R&D investments will promote the leukemia screening market in Asia Pacific. Middle East Africa and Latin America leukemia screening market are projected to grow significantly due to rising disposable income and increasing prevalence of leukemia.
In 2018, the global Leukemia Screening market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Leukemia Screening status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Leukemia Screening development in United States, Europe and China.

The key players covered in this study
Abbott
Abbvie
GE Healthcare
Siemens Healthcare
Philips Healthcare
Toshiba Medical Systems
Hitachi Medical Systems
Varian Medical Systems
Shimadzu Corporation

Market segment by Type, the product can be split into
Bone Marrow Aspiration and Biopsy
Chest X-Ray or Chest CAT Scan
Spinal Tap

Market segment by Application, split into
Cancer Research Centers
Diagnostic Laboratories
Clinics
Hospitals

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Leukemia Screening status, future forecast, growth opportunity, key market and key players.
To present the Leukemia Screening development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Leukemia Screening are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Leukemia Screening Market Size Growth Rate by Type (2014-2025)
1.4.2 Bone Marrow Aspiration and Biopsy
1.4.3 Chest X-Ray or Chest CAT Scan
1.4.4 Spinal Tap
1.5 Market by Application
1.5.1 Global Leukemia Screening Market Share by Application (2014-2025)
1.5.2 Cancer Research Centers
1.5.3 Diagnostic Laboratories
1.5.4 Clinics
1.5.5 Hospitals
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Leukemia Screening Market Size
2.2 Leukemia Screening Growth Trends by Regions
2.2.1 Leukemia Screening Market Size by Regions (2014-2025)
2.2.2 Leukemia Screening Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Leukemia Screening Market Size by Manufacturers
3.1.1 Global Leukemia Screening Revenue by Manufacturers (2014-2019)
3.1.2 Global Leukemia Screening Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Leukemia Screening Market Concentration Ratio (CR5 and HHI)
3.2 Leukemia Screening Key Players Head office and Area Served
3.3 Key Players Leukemia Screening Product/Solution/Service
3.4 Date of Enter into Leukemia Screening Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Leukemia Screening Market Size by Type (2014-2019)
4.2 Global Leukemia Screening Market Size by Application (2014-2019)

5 United States
5.1 United States Leukemia Screening Market Size (2014-2019)
5.2 Leukemia Screening Key Players in United States
5.3 United States Leukemia Screening Market Size by Type
5.4 United States Leukemia Screening Market Size by Application

6 Europe
6.1 Europe Leukemia Screening Market Size (2014-2019)
6.2 Leukemia Screening Key Players in Europe
6.3 Europe Leukemia Screening Market Size by Type
6.4 Europe Leukemia Screening Market Size by Application

7 China
7.1 China Leukemia Screening Market Size (2014-2019)
7.2 Leukemia Screening Key Players in China
7.3 China Leukemia Screening Market Size by Type
7.4 China Leukemia Screening Market Size by Application

8 Japan
8.1 Japan Leukemia Screening Market Size (2014-2019)
8.2 Leukemia Screening Key Players in Japan
8.3 Japan Leukemia Screening Market Size by Type
8.4 Japan Leukemia Screening Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Leukemia Screening Market Size (2014-2019)
9.2 Leukemia Screening Key Players in Southeast Asia
9.3 Southeast Asia Leukemia Screening Market Size by Type
9.4 Southeast Asia Leukemia Screening Market Size by Application

10 India
10.1 India Leukemia Screening Market Size (2014-2019)
10.2 Leukemia Screening Key Players in India
10.3 India Leukemia Screening Market Size by Type
10.4 India Leukemia Screening Market Size by Application

11 Central & South America
11.1 Central & South America Leukemia Screening Market Size (2014-2019)
11.2 Leukemia Screening Key Players in Central & South America
11.3 Central & South America Leukemia Screening Market Size by Type
11.4 Central & South America Leukemia Screening Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Leukemia Screening Introduction
12.1.4 Abbott Revenue in Leukemia Screening Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 Abbvie
12.2.1 Abbvie Company Details
12.2.2 Company Description and Business Overview
12.2.3 Leukemia Screening Introduction
12.2.4 Abbvie Revenue in Leukemia Screening Business (2014-2019)
12.2.5 Abbvie Recent Development
12.3 GE Healthcare
12.3.1 GE Healthcare Company Details
12.3.2 Company Description and Business Overview
12.3.3 Leukemia Screening Introduction
12.3.4 GE Healthcare Revenue in Leukemia Screening Business (2014-2019)
12.3.5 GE Healthcare Recent Development
12.4 Siemens Healthcare
12.4.1 Siemens Healthcare Company Details
12.4.2 Company Description and Business Overview
12.4.3 Leukemia Screening Introduction
12.4.4 Siemens Healthcare Revenue in Leukemia Screening Business (2014-2019)
12.4.5 Siemens Healthcare Recent Development
12.5 Philips Healthcare
12.5.1 Philips Healthcare Company Details
12.5.2 Company Description and Business Overview
12.5.3 Leukemia Screening Introduction
12.5.4 Philips Healthcare Revenue in Leukemia Screening Business (2014-2019)
12.5.5 Philips Healthcare Recent Development
12.6 Toshiba Medical Systems
12.6.1 Toshiba Medical Systems Company Details
12.6.2 Company Description and Business Overview
12.6.3 Leukemia Screening Introduction
12.6.4 Toshiba Medical Systems Revenue in Leukemia Screening Business (2014-2019)
12.6.5 Toshiba Medical Systems Recent Development
12.7 Hitachi Medical Systems
12.7.1 Hitachi Medical Systems Company Details
12.7.2 Company Description and Business Overview
12.7.3 Leukemia Screening Introduction
12.7.4 Hitachi Medical Systems Revenue in Leukemia Screening Business (2014-2019)
12.7.5 Hitachi Medical Systems Recent Development
12.8 Varian Medical Systems
12.8.1 Varian Medical Systems Company Details
12.8.2 Company Description and Business Overview
12.8.3 Leukemia Screening Introduction
12.8.4 Varian Medical Systems Revenue in Leukemia Screening Business (2014-2019)
12.8.5 Varian Medical Systems Recent Development
12.9 Shimadzu Corporation
12.9.1 Shimadzu Corporation Company Details
12.9.2 Company Description and Business Overview
12.9.3 Leukemia Screening Introduction
12.9.4 Shimadzu Corporation Revenue in Leukemia Screening Business (2014-2019)
12.9.5 Shimadzu Corporation Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details